Orora Limited

ORA

Orora Ltd. engages in the manufacturing and distribution of fiber, glass and aluminum beverage cans. The company is headquartered in Hawthorn, Victoria and currently employs 4,657 full-time employees. The company went IPO on 2013-12-18. The company supplies packaging products and services to the grocery, fast moving consumer goods and industrial markets. The Company’s Australasia segment focuses on the manufacture of beverage packaging products within Australia and New Zealand. Its North America segment is predominately located in North America, which purchases, warehouses, sells and delivers a range of packaging and other related materials. The business also includes integrated corrugated sheet and box manufacturing and equipment sales capabilities and point of purchase retail display solutions and other visual communication services. Its Saverglass business is engaged in the design, manufacturing, customization and decoration of high-end bottles and provides for the premium and super-premium spirits, fine wine and champagne markets.

Ordell Minerals Limited

ORD

Ordell Minerals Ltd is a AU-based company operating in Metals & Mining industry. The company is headquartered in Perth, Western Australia. The company went IPO on 2024-07-19. Ordell Minerals Limited is an Australia-based mineral exploration company. The firm has a prospective gold and lithium exploration portfolio, which includes three principal mineral assets: the Barimaia Joint Venture (JV) Project, the Goodia Project and the Fisher South Project located in the Yilgarn Craton of Western Australia (WA), Australia. The combined properties cover approximately 308 square kilometers (km2). The Barimaia JV Project comprises one mining lease, one exploration lease and 14 prospecting licenses in the Youanmi Terrane of the Yilgarn Craton near Mt Magnet. The Goodia Project is located within the eastern Goldfields region of WA and has the potential to host economic gold, nickel or lithium deposits. The project comprises one tenement E63/2313 and covers approximately 75km2. The Fisher South Project is located in the north-eastern Goldfields of WA, approximately 430km north of Kalgoorlie and comprises one tenement E53/2143, covering an area of 62 blocks (190km2).

Opthea Limited

OPT

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. The company is headquartered in Melbourne, Victoria. The firm is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The firm has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).